Plunkett Research Online: Acorda Therapeutics Inc

ACORDA THERAPEUTICS INC (ACOR:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Acorda Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies that restore function within people who have neurological disorders. The firm markets Inbrija (levodopa inhalation powder), which is approved in the U.S. for intermittent treatment of OFF episodes in people wit.....



Acorda Therapeutics Inc
Ticker: ACOR
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 914-347-4300
Fax: 914-347-4560
Address: 420 Saw Mill River Road
Ardsley, NY 10502 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
Contacts Description

Ron Cohen CEO/Director/Founder/President
David Lawrence Chief Accounting Officer/Other Executive Officer
See More
Acorda Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies that restore function within people who have neurological disorders. The firm markets Inbrija (levodopa inhalation powder), which is approved in the U.S. for intermittent treatment of OFF episodes in people wit.....See More See More

Auditor: Ernst &Young, LLP
Legal Advisor: Covington & Burling LLP
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Inbrija
Ampyra
BTT1023
SYN120
GGF2
rHIgM22
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: